908 Devices
Highly Engaged Employees
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
645 Summer St, Boston, Massachusetts, 02...Phone Number
(857) 254-1500Website
www.908devices.comRevenue
$57.8 MillionStock Symbol
MASSIndustry
About 908 Devices
908 Devices Org Chart
Is 908 Devices your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if 908 Devices had a recent Job posting/layoffs
908 Devices, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once 908 Devices has new funding data
Congratulate Masked Content for being promoted to Masked Content at 908 Devices
Check if 908 Devices has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when 908 Devices launches new products
Earning: See what the market has to say on 908 Devices recently announced quarterly report
Check out if 908 Devices is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to 908 Devices
Compare insights from companies similar to 908 Devices, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
908 Devices is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
908 Devices is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about 908 Devices.
908 Devices financials insights
Gather financial insights about 908 Devices, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$8.1M
Series B
$7M
Private Equity
$2.6M
Series C
$11.6M
Private Equity
$20M
Other Financing Round
$17.5M
Stock Offering
$130M
908 Devices Tech Stack
A closer look at the technologies used by 908 Devices
Most Recent Scoops
908 Devices News & Media
908 Devices Inc. (MASS): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential
We recently published an article titled Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential. In this article, we are going to take a look at where 908 Devices Inc. (NASDAQ:MASS) stands against Nicholas J. Pritzker’s other stock picks with huge upside potential. Nicholas J. Pritzker is the chairman and co-founder of Tao Capital Partners, […]908 Devices Announces Preliminary First Quarter 2025 Financial Results
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for safety and defense tech applications, today announced preliminary unaudited financial results for the quarter ended March 31, 2025. Preliminary unaudited revenue from continuing operations for the first quarter of 2025 is expected to be at least $11.5 million, compared to $7.4 million of revenue from continuing operations in the first quarter ofRepligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
WALTHAM, Mass., & BOSTON--(BUSINESS WIRE)--Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld and desktop devices for chemical analysis, announce that Repligen has purchased 908 Devices’ desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. 908 Devices remains focused on the growth of its newly expanded handheld deviceGetinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters
BOSTON--(BUSINESS WIRE)-- #automation--Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for automated control of glucose and lactate levels in cell cultures. The combined solution will help scientists measure critical process parameters in bioreactors, offering continuous, real-time analysis without the need for manual sampling. In the field of bioprocessing, the continuous monitoring of glucose and lactate
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding 908 Devices
908 Devices is portrayed as an innovator in chemical analysis, creating compact handheld tools that simplify the identification of unknown or hidden substances. The company focuses on delivering rapid, actionable insights at the point of need, supporting critical health and safety efforts that span the drug crisis, hazardous exposure risks, and glo... Read More

